Search for: "Abbott Laboratories, Inc." Results 101 - 120 of 407
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Oct 2011, 3:26 am by Ben Vernia
The investigation determined that the pharmaceutical manufacturers Abbott Laboratories, Dey Inc. and Roxane Laboratories reported falsely inflated drug prices relied upon by the Medicare and Medicaid programs to determine reimbursements to pharmacies. [read post]
5 Dec 2011, 8:59 am by Kara M. Maciel
Abbott Laboratories, Inc., the Eastern District of Pennsylvania issued the latest ruling in the ongoing dispute over whether pharmaceutical sales representatives are exempt from the overtime requirements of the FLSA. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/22: Abbott Laboratories and Abbott Respiratory LLC v. [read post]
30 Jun 2023, 1:56 pm by Javier Dominguez
Arriva was acquired a decade ago by Alere Inc., now part of Abbott, and the high court “has made clear that they cannot escape liability by hiding behind after-the-fact interpretations of federal laws that Mr. [read post]
24 Nov 2008, 2:09 am
Teva Pharmaceuticals USA, Inc. et al.1:08-cv-06659; filed November 20, 2008 in the Northern District of IllinoisInfringement of U.S. [read post]
21 Oct 2016, 7:47 am by Ben Vernia
According to DOJ’s press release: The nation’s largest nursing home pharmacy, Omnicare Inc., has agreed to pay $28.125 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription drug, Depakote, for nursing home patients. [read post]
9 Dec 2010, 4:40 am by Ben Vernia
According to DOJ’s press release the company will pay $41 million and enter into a Deferred Prosecution Agreement: Kos Pharmaceuticals, a subsidiary of Abbott Laboratories, has agreed to pay more than $41 million to resolve criminal and civil liability arising from conduct relating to its drugs Advicor and Niaspan, the Justice Department announced today. [read post]
13 Nov 2008, 5:27 pm
As of July 2008, twenty-five states and the District of Columbia have filed antitrust suits against Abbott Laboratories and Solvay's Fournier Industrie et Santé and Laboratories Fournier in Delaware District Court, charging them with blocking generic competition by engaging in product hopping, among other “anti-generic strategies. [read post]
28 Mar 2022, 7:30 pm by Bill Marler
At this time, CDC has completed laboratory testing for the two available patient samples. [read post]
5 Dec 2011, 8:59 am by <a href=''>Kara M. Maciel</a>
Abbott Laboratories, Inc., the Eastern District of Pennsylvania issued the latest ruling in the ongoing dispute over whether pharmaceutical sales representatives are exempt from the overtime requirements of the FLSA. [read post]
23 Oct 2012, 4:01 am by Sean Wajert
See In re Abbott Laboratories Inc., No. 12-8020 (7th Cir. 10/16/12). [read post]